The EDC is live today — see what ships now
All studies
NCT00271622From ClinicalTrials.govRecruiting

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

Neurodevelopmental and Behavioral Phenotyping Screening Protocol

  • Neurologic Disorders
  • Autism
  • Neurodegenerative Disease
  • Neurobehavioral Manifestation

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
National Institute of Mental Health (NIMH)
Enrolment target
5,000
Started
27 February 2006
Main results due
Not stated
Study sites
1
Registry updated
29 September 2026

Can you take part?

  • Aged 6 weeks and over.
  • Open to any sex.
  • Healthy volunteers can take part.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
* INCLUSION CRITERIA:
* Subjects must be at least 6 weeks of age.
* Subjects or their parents must be competent to comprehend the purpose of the screening process and to provide written informed consent. Parents/guardians will sign the consent form, and both minors and adults (depending on results of capacity assessment) will be asked to assent only if it is determined that they understand their role in the study.
* Subjects must be willing to undergo an evaluation which may include a psychiatric interview; and medical, neurological, and laboratory examinations (as appropriate, such as renal and liver function tests, serum electrolytes, urinalysis, blood levels of psychotropic drugs, and urine drug screen for the presence of psychoactive drugs and drugs of abuse, as determined on a subject-to-subject basis).

EXCLUSION CRITERIA:

-Lack of appropriate consent: For minor patients, consent must be obtained from all legal guardians/caretakers, including both parents in separated or divorced families where there is shared legal custody of the child. In such cases, both parents must consent to the child s participation in this protocol.

What this study is about

In the sponsor’s own words, from the registry.

The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.

Study sites(1)

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, United States

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT00271622. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol | Trialion